GLAXOSMITHKLINE PHARMACEUTICALS
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹1,385 Cr | ₹1,255 Cr | ₹960 Cr | ₹841 Cr | ₹2,476 Cr |
| Adjustment | ₹-65 Cr | ₹-68 Cr | ₹-45 Cr | ₹-40 Cr | ₹-1,636 Cr |
| Changes In working Capital | ₹-98 Cr | ₹185 Cr | ₹61 Cr | ₹-46 Cr | ₹120 Cr |
| Cash Flow after changes in Working Capital | ₹1,222 Cr | ₹1,372 Cr | ₹976 Cr | ₹756 Cr | ₹959 Cr |
| Cash Flow from Operating Activities | ₹903 Cr | ₹1,290 Cr | ₹582 Cr | ₹484 Cr | ₹811 Cr |
| Cash Flow from Investing Activities | ₹397 Cr | ₹-46 Cr | ₹8.71 Cr | ₹808 Cr | ₹-406 Cr |
| Cash Flow from Financing Activities | ₹-737 Cr | ₹-769 Cr | ₹-561 Cr | ₹-1,543 Cr | ₹-524 Cr |
| Net Cash Inflow / Outflow | ₹563 Cr | ₹475 Cr | ₹29 Cr | ₹-251 Cr | ₹-119 Cr |
| Opening Cash & Cash Equivalents | ₹539 Cr | ₹64 Cr | ₹35 Cr | ₹286 Cr | ₹405 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹1,102 Cr | ₹539 Cr | ₹64 Cr | ₹35 Cr | ₹286 Cr |
Compare Cashflow Statement of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,902.2 Cr | 3.1% | -7.3% | -4.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,122.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,424.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,914.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,599.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹113,112.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 3.1% |
-7.3% |
-4.9% |
| SENSEX | 5.5% |
7.5% |
-8.7% |
You may also like the below Video Courses